Roger O'Sullivan PLLC November 3rd:
FDA Accepts Arana's Anti-inflammatory IND

September 4th:
Cytopia Commences Second Phase II Study in Brain Cancer

September 4th:
Pharmaxis Announces Second Pivotal Phase 3 Trial in Cystic Fibrosis Begins

more news >


Upcoming Events

Feb, 2008:
BIO CEO & Investor Conference

more events >
 
O'Sullivan PLLC   eG Capital Partnership
BioMelbourneBioMelbourne NewsletterNew York Biotech AssociationAustBiotechLab To Wall Street  

Disclaimer